SQZ Biotechnologies

Biotechnology ResearchMassachusetts, United States51-200 Employees

SQZ Biotechnologies is a clinical-stage biotechnology company based in Watertown, Massachusetts, focused on advancing cell therapies for cancer, autoimmune, and infectious diseases. Its core capability centers on a proprietary Cell Squeeze technology that enables delivery of multiple biological materials into diverse patient cell types to engineer a broad range of potential therapeutics. The company aims to develop well-tolerated cell therapies that can provide therapeutic benefit and improve the patient experience compared with existing cell therapy approaches. Its first therapeutic applications seek to generate target-specific immune responses, both in activation for the treatment of solid tumors and in immune tolerance for the treatment of unwanted immune reactions and autoimmune diseases. 

Its product strategy includes accelerating production timelines—reducing manufacturing to under 24 hours—and the potential to eliminate preconditioning and lengthy hospital stays. The initial therapeutic applications aim to elicit target-specific immune responses, including activation against solid tumors and tolerance for unwanted immune reactions and autoimmune diseases.

Sign up for free to view info

Email Format Employee directory